肺组织多层网络分析揭示慢阻肺分子异质性
研究对135例 former smokers 的慢阻肺患者肺组织进行mRNA、microRNA和甲基化组检测,构建多层网络识别患者社区。发现五个分子异质性社区与FEV1和血嗜酸性粒细胞相关,其中两个社区FEV1与肺气肿相似但分子不同。结论提示相似临床表现可由不同内型导致。
要点
- 多层网络整合多组学可识别慢阻肺临床相关患者社区
- FEV1和肺气肿相似的患者可存在分子异质的小气道与免疫模式
- C#3社区具有B/T细胞特征及分泌细胞和纤毛细胞下调
核心结论
- 多层网络分析能识别临床相关的慢阻肺患者社区,相似FEV1和肺气肿患者可有分子异质的小气道和免疫应答模式,提示不同内型可导致相似临床表现。
研究设计与样本
- 对135例 former smokers 的慢阻肺患者肺组织样本进行mRNA、microRNA和甲基化组检测,基于分子相似性构建患者网络并整合为多层网络,优化多重模块度识别跨层患者社区并与临床特征关联。
主要发现
- 多层网络中识别出五个分子异质且与FEV1和血嗜酸性粒细胞等临床特征相关的患者社区。
- C#3和C#4社区FEV1值均较低且均有肺气肿,但分子不同:C#3呈现B细胞和T细胞特征及分泌细胞(SCGB1A1/SCGB3A1)和纤毛细胞下调,C#4无此表现。
- 建立机器学习模型区分C#3和C#4并在独立队列中验证。
- 空间转录组学显示C#3小气道中T/B细胞归巢趋化因子和细菌应答基因上调。
临床怎么用
- 对FEV1和肺气肿相似的患者,可考虑分子分型以识别不同内型,指导针对性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition. Objectives: We hypothesized that the unbiased integration of different COPD lung omics using a novel multilayer approach might unravel mechanisms associated with clinical characteristics. Methods: We profiled mRNA, microRNA and methylome in lung tissue samples from 135 former smokers with COPD. For each omic (layer), we built a patient network on the basis of molecular similarity. The three networks were used to build a multilayer network, and optimization of multiplex modularity was used to identify patient communities across the three distinct layers. Uncovered communities were related to clinical features. Measurements and Main Results: We identified five patient communities in the multilayer network that were molecularly distinct and related to clinical characteristics, such as FEV1 and blood eosinophils. Two communities (C#3 and C#4) had both similarly low FEV1 values and emphysema but were molecularly different: C#3, but not C#4, presented B- and T-cell signatures and a downregulation of secretory (SCGB1A1/SCGB3A1) and ciliated cells. A machine learning model was set up to discriminate C#3 and C#4 in our cohort and to validate them in an independent cohort. Finally, using spatial transcriptomics, we characterized the small airway differences between C#3 and C#4, identifying an upregulation of T-/B-cell homing chemokines and bacterial response genes in C#3. Conclusions: A novel multilayer network analysis is able to identify clinically relevant COPD patient communities. Patients with similarly low FEV1 and emphysema can have molecularly distinct small airways and immune response patterns, indicating that different endotypes can lead to similar clinical presentation.
引用
- Olvera N, Sánchez-Valle J, Núñez-Carpintero I, et al. Lung Tissue Multilayer Network Analysis Uncovers the Molecular Heterogeneity of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024. PMID: 38626356. doi:10.1164/rccm.202303-0500OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。